{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-0", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 0, "text": "COVID-19 Vaccine, Viral Vector (Janssen [Johnson and Johnson]): MedlinePlus Drug Information\nwebsite belongs to an official government organization in the United States.\n(\nLock\nmeans you've safely connected to the .gov website. Share sensitive information only on official, secure websites.\n→\n→\nCOVID-19 Vaccine, Viral Vector (Janssen [Johnson and Johnson])\nCOVID-19 Vaccine, Viral Vector (Janssen [Johnson and Johnson])\nWhat is COVID-19?\nHow is the Janssen (Johnson and Johnson) COVID-19 vaccine given?\nWhat should you tell the person who is giving the vaccine?\nWhat are the benefits of the Janssen (Johnson and Johnson) vaccine?\nWhat are the risks of the Janssen (Johnson and Johnson) vaccine?\nWhat should I do about side effects?\nWill the Janssen (Johnson and Johnson) vaccine give me COVID-19?\nKeep your vaccination card\nWhere will my vaccination information be recorded?\nHow can I learn more?\nCan I be charged an administration fee for receiving the COVID-19 vaccine?\nWhere can I report cases of suspected fraud?\nWhat is the Countermeasures Injury Compensation Program?\nOther names\nNotice:\nCOVID-19 Vaccine, Viral Vector (Johnson and Johnson/Janssen) is no longer commercially available in the U"}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-1", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 1, "text": "suspected fraud?\nWhat is the Countermeasures Injury Compensation Program?\nOther names\nNotice:\nCOVID-19 Vaccine, Viral Vector (Johnson and Johnson/Janssen) is no longer commercially available in the U.S and the Emergency Use Authorization has been revoked as of 6/1/2023. Please see the following for more information:\nhttps://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/janssen-covid-19-vaccine\nIMPORTANT WARNING:\nThe Janssen (Johnson and Johnson) coronavirus disease 2019 (COVID-19) vaccine is currently being studied to prevent coronavirus disease 2019 caused by the SARS-CoV-2 virus.\nInformation from clinical trials is available at this time to support the use of Janssen (Johnson and Johnson) COVID-19 vaccine to prevent COVID-19. In clinical trials, approximately 21,895 individuals 18 years of age and older have received the Janssen (Johnson and Johnson) COVID-19 vaccine. Millions of people have received the vaccine under EUA since February 27, 2021.\nJanssen (Johnson and Johnson) COVID-19 vaccine has not undergone the standard review to be approved by the FDA for use."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-2", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 2, "text": "Millions of people have received the vaccine under EUA since February 27, 2021.\nJanssen (Johnson and Johnson) COVID-19 vaccine has not undergone the standard review to be approved by the FDA for use. However, the FDA has also approved an EUA for the Janssen (Johnson and Johnson) COVID-19 vaccine to allow:\na\nsingle primary dose\nto people 18 years and older who are unable to receive or unwilling to receive other FDA-authorized or -approved COVID-19 vaccines.\na\nsingle booster dose\nat least 2 months after the first dose of the Janssen (Johnson and Johnson) COVID-19 vaccine for people 18 years and older who are unable to receive or unwilling to receive other FDA-authorized or -approved COVID-19 vaccines.\na\nsingle booster dose\nto people 18 years of age and older who have completed primary vaccination with a different authorized or approved COVID-19 vaccine who are unable to receive or unwilling to receive other FDA-authorized or -approved COVID-19 vaccines.\nTalk to your doctor about the risks and benefits of receiving this medication.\nJanssen (Johnson and Johnson) COVID-19 vaccine may cause life-threatening blood clots."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-3", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 3, "text": "d or -approved COVID-19 vaccines.\nTalk to your doctor about the risks and benefits of receiving this medication.\nJanssen (Johnson and Johnson) COVID-19 vaccine may cause life-threatening blood clots. Symptoms of blood clots can include shortness of breath, chest pain. leg swelling. persistent abdominal pain, severe or persistent headaches, blurred vision, or petechiae (tiny red or purple spots on the skin) and may occur 1 to 2 weeks after vaccination. If any of these symptoms should occur, seek immediate medical attention. If you have a history of blood clots with low platelets following the Janssen (Johnson and Johnson) COVID-19 vaccine or AstraZeneca (not currently approved in the US) COVID-19 vaccines, you should not receive the Janssen (Johnson and Johnson) COVID-19 vaccine.\nWhat is COVID-19?\nCOVID-19 disease is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory (lung) illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-4", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 4, "text": "he virus. It is predominantly a respiratory (lung) illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever, chills, cough, shortness of breath, fatigue, muscle or body aches, headache, loss of taste or smell, sore throat, congestion, runny nose, nausea, vomiting, or diarrhea.\nHow is the Janssen (Johnson and Johnson) COVID-19 vaccine given?\nThe Janssen (Johnson and Johnson) COVID-19 vaccine will be given to you as an injection into the muscle. The Janssen (Johnson and Johnson) COVID-19 vaccine vaccination is given as a one-time dose.\nThe FDA has also approved an EUA for the Janssen (Johnson and Johnson) COVID-19 vaccine to allow:\na\nsingle booster dose\nat least two months after completion of the primary vaccination of Janssen (Johnson and Johnson) COVID-19 vaccine.\na\nsingle booster dose\nto people 18 years of age and older who have completed primary vaccination with a different authorized or approved COVID-19 vaccine."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-5", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 5, "text": "ssen (Johnson and Johnson) COVID-19 vaccine.\na\nsingle booster dose\nto people 18 years of age and older who have completed primary vaccination with a different authorized or approved COVID-19 vaccine. Please check with your healthcare provider regarding eligibility for and timing of the booster.\nWhat should you tell the person who is giving the vaccine?\nTell your vaccine provider about all of your medical conditions, including if you:\nhave any allergies.\nhave a fever.\nhave a bleeding disorder or are on a blood thinner such as warfarin (Coumadin, Jantoven).\nare immunocompromised (weakened immune system) or are on a medicine that affects your immune system.\nare pregnant or plan to become pregnant.\nare breastfeeding.\nhave received another COVID-19 vaccine.\nhave ever fainted in association with an injection.\nhave had a serious allergic reaction to any ingredient in this vaccine.\nWhat are the benefits of the Janssen (Johnson and Johnson) vaccine?\nIn an ongoing clinical trial, the Janssen (Johnson and Johnson) COVID-19 vaccine has been shown to prevent COVID-19 after a single dose."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-6", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 6, "text": "are the benefits of the Janssen (Johnson and Johnson) vaccine?\nIn an ongoing clinical trial, the Janssen (Johnson and Johnson) COVID-19 vaccine has been shown to prevent COVID-19 after a single dose. How long you are protected against COVID-19 is currently unknown.\nWhat are the risks of the Janssen (Johnson and Johnson) vaccine?\nSide effects that have been reported with the Janssen (Johnson and Johnson) COVID-19 vaccine include:\ninjection site pain, swelling, and redness\nheadache, feeling very tired, muscle aches, nausea, and fever\nswollen lymph nodes\nunusual feeling in the skin, such as tingling or a crawling feeling or decreased feeling or sensitivity\nongoing ringing in the ears\ndiarrhea, vomiting\nThere is a remote chance that the Janssen (Johnson and Johnson) COVID-19 vaccine could cause a severe allergic reaction."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-7", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 7, "text": "ecreased feeling or sensitivity\nongoing ringing in the ears\ndiarrhea, vomiting\nThere is a remote chance that the Janssen (Johnson and Johnson) COVID-19 vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of the Janssen (Johnson and Johnson) COVID-19 vaccine.\nSigns of a severe allergic reaction can include:\ndifficulty breathing\nswelling of your face and throat\na fast heartbeat\na bad rash all over your body\ndizziness and weakness\nGuillain-BarrÃ© syndrome (a nervous system disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis) has occurred in some people who have received the Janssen (Johnson and Johnson) COVID-19 vaccine. In most of these people, symptoms began within 42 days (6 weeks) after receiving the Janssen (Johnson and Johnson) COVID-19 vaccine. The chance of having this occur is very low."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-8", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 8, "text": "on) COVID-19 vaccine. In most of these people, symptoms began within 42 days (6 weeks) after receiving the Janssen (Johnson and Johnson) COVID-19 vaccine. The chance of having this occur is very low. You should seek medical attention right away if you develop any of the following symptoms after receiving the Janssen COVID-19 vaccine:\nweakness or tingling sensations, especially in the legs or arms, that's worsening and spreading to other parts of the body\ndifficulty walking\nproblems with facial movements, including speaking, chewing, or swallowing\ndouble vision or inability to move your eyes\nproblems with bladder control or bowel function\nThese may not be all the possible side effects of the Janssen (Johnson and Johnson) COVID-19 vaccine. Serious and unexpected side effects may occur."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-9", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 9, "text": "es\nproblems with bladder control or bowel function\nThese may not be all the possible side effects of the Janssen (Johnson and Johnson) COVID-19 vaccine. Serious and unexpected side effects may occur. Janssen (Johnson and Johnson) COVID-19 vaccine is still being studied in clinical trials.\nWhat should I do about side effects?\nIf you experience a severe allergic reaction, call 9-1-1 or go to the nearest hospital.\nCall the vaccination provider or your healthcare provider if you have any side effects that bother you or do not go away.\nReport vaccine side effects to\nFDA/CDC Vaccine Adverse Event Reporting System (VAERS)\n. The VAERS toll-free number is\n1-800-822-7967\n, or report online to\nhttps://vaers.hhs.gov/reportevent.html\n. Please include \"Janssen COVID-19 Vaccine EUA\" in the first line of box #18 of the report form.\nIn addition, you can report side effects to Janssen Biotech, Inc. at\n1-800-565-4008\nor JNJvaccineAE@its.jnj.com.\nYou may also be given an option to enroll in v-safe. V-safe is a new voluntary smartphone-based tool that uses text messaging and web surveys to check in with people who have been vaccinated to identify potential side effects after COVID-19 vaccination."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-10", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 10, "text": "-safe is a new voluntary smartphone-based tool that uses text messaging and web surveys to check in with people who have been vaccinated to identify potential side effects after COVID-19 vaccination. V-safe asks questions that help CDC monitor the safety of COVID-19 vaccines. V-safe also provides live telephone follow-up by CDC if participants report a significant health impact following COVID-19 vaccination. For more information on how to sign up, visit:\nhttps://www.cdc.gov/vsafe\n.\nWill the Janssen (Johnson and Johnson) vaccine give me COVID-19?\nNo. The Janssen (Johnson and Johnson) COVID-19 vaccine does not contain SARS-CoV-2 and cannot give you COVID-19.\nKeep your vaccination card\nWhen you get your dose, you will get a vaccination card. Remember to bring your card when you return for additional doses.\nWhere will my vaccination information be recorded?\nThe vaccination provider may include your vaccination information in your state/local jurisdiction's Immunization Information System (IIS) or other designated system."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-11", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 11, "text": "ination information be recorded?\nThe vaccination provider may include your vaccination information in your state/local jurisdiction's Immunization Information System (IIS) or other designated system. For more information about IISs visit:\nhttps://www.cdc.gov/vaccines/programs/iis/about.html\n.\nHow can I learn more?\nAsk the vaccination provider.\nVisit CDC at\nhttps://bit.ly/3vyvtNB\n.\nVisit FDA at\nhttps://bit.ly/3qI0njF\n.\nContact your local or state public health department.\nCan I be charged an administration fee for receiving the COVID-19 vaccine?\nNo. At this time, the provider cannot charge you for a vaccine dose and you cannot be charged an out-of-pocket vaccine administration fee or any other fee if only receiving a COVID-19 vaccination."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-12", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 12, "text": "e?\nNo. At this time, the provider cannot charge you for a vaccine dose and you cannot be charged an out-of-pocket vaccine administration fee or any other fee if only receiving a COVID-19 vaccination. However, vaccination providers may seek appropriate reimbursement from a program or plan that covers COVID-19 vaccine administration fees for the vaccine recipient (private insurance, Medicare, Medicaid, HRSA COVID-19 Uninsured Program for non-insured recipients).\nWhere can I report cases of suspected fraud?\nIndividuals becoming aware of any potential violations of the CDC COVID-19 Vaccination Program requirements are encouraged to report them to the Office of the Inspector General, U.S. Department of Health and Human Services, at 1-800-HHS-TIPS or TIPS.HHS.GOV.\nWhat is the Countermeasures Injury Compensation Program?\nThe Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs of medical care and other specific expenses of certain people who have been seriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one year from the date of receiving the vaccine."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-13", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 13, "text": "ople who have been seriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one year from the date of receiving the vaccine. To learn more about this program, visit\nhttp://www.hrsa.gov/cicp/\nor call\n1-855-266-2427\n.\nThe American Society of Health-System Pharmacists, Inc. represents that this information about the Janssen (Johnson and Johnson) COVID-19 vaccine was formulated with a reasonable standard of care, and in conformity with professional standards in the field. Readers are cautioned that the Janssen (Johnson and Johnson) COVID-19 vaccine is not an approved vaccine for coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, but rather, is being investigated for and is currently available under an FDA emergency use authorization (EUA) to prevent COVID-19 in certain adults. The American Society of Health-System Pharmacists, Inc. makes no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to the information, and specifically disclaims all such warranties."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-14", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 14, "text": "plied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to the information, and specifically disclaims all such warranties. Readers of the information about the Janssen (Johnson and Johnson) COVID-19 vaccine are advised that ASHP is not responsible for the continued currency of the information, for any errors or omissions, and/or for any consequences arising from the use of this information. Readers are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information contained in this information is provided for informational purposes only. The American Society of Health-System Pharmacists, Inc. does not endorse or recommend the use of any drug. This information about the Janssen (Johnson and Johnson) COVID-19 vaccine is not to be considered individual patient advice."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007-15", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621007.txt", "chunk_index": 15, "text": "ystem Pharmacists, Inc. does not endorse or recommend the use of any drug. This information about the Janssen (Johnson and Johnson) COVID-19 vaccine is not to be considered individual patient advice. Because of the changing nature of drug information, you are advised to consult with your physician or pharmacist about specific clinical use of any and all medications.\nOther names\nAdenoviral vector COVID-19 vaccine\nAdenovirus 26 vector COVID-19 vaccine\nAd26.COV2.S\nCOVID-19 Vaccine, Johnson and Johnson\nLast Revised -\n07/15/2023"}
